Impotence

N14_IMPOTENCE

erectile dysfunction: Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N48.4 Hospital discharge: ICD-9 — 6078B Cause of death: ICD-10 — N48.4 Cause of death: ICD-9 — 6078B 2 out of 7 registries used, show all original rules.	1993
4. Check minimum number of events None	1993
5. Include endpoints None	1993
6. Filter based on genotype QC (FinnGen only)	1993

Control definitions (FinnGen only)

Control exclude: N14_MALEGEN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N48
Name in latin: Impotentia organica

NAME	N14_IMPOTENCE
CONTROL_EXCLUDE	N14_MALEGEN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N484
HD_ICD_9	6078B
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N484
COD_ICD_9	6078B
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Impotence based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	10197	-	10197
Only index persons	9386	-	9386
Unadjusted period prevalence (%)
Whole population	0.28	-	0.28
Only index persons	0.36	-	0.36
Median age at first event (years)
Whole population	-	-	57.03
Only index persons	-	-	56.63

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1993	-	1993
Unadjusted period prevalence (%)	0.88	-	0.88
Median age at first event (years)	59.77	-	59.77

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1771: Matched controls
17710

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N48.4

ICD-10 Finland

Impotence of organic origin

3325.5

323.0

1696

116

N40

ICD-10 Finland

Hyperplasia of prostate

6.5

215.8

678

1546

XKD00

NOMESCO Finland

Uroflowmetry

6.1

178.4

570

1277

G04BE01

ATC

alprostadil; parenteral, urethral

12.9

130.2

241

214

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

5.8

129.5

413

880

UKC02

NOMESCO Finland

Cystoscopy

4.9

121.1

459

1181

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

5.1

116.1

420

1023

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

7.1

114.1

302

497

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

11.7

111.5

215

206

KED22

NOMESCO Finland

Transurethral resection of prostate

31.5

110.5

148

6078B

ICD-9 Finland

Disorders of penis, Other specified disorders of penis[IMPOTENTIA ORGANICA]

+∞

106.3

101

KGV30

NOMESCO Finland

Implantation of prosthesis into penis

+∞

83.0

XJH00

NOMESCO Finland

Transanal ultrasonography

6.2

71.6

206

369

N48.8

ICD-10 Finland

Other specified disorders of penis

100.6

70.5

G04CA02

ATC

tamsulosin; oral

2.6

68.9

697

3540

KGH10

NOMESCO Finland

Operation for phimosis

71.0

65.8

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

34.3

65.1

G04BE03

ATC

sildenafil; oral

9.8

63.8

133

145

XKG00

NOMESCO Finland

Artificial induction of erection

72.6

61.6

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

3.6

61.0

316

1020

J01MA02

ATC

ciprofloxacin; systemic

2.4

58.4

740

4138

G04CA01

ATC

alfuzosin; oral

3.0

57.5

385

1492

J01EA01

ATC

trimethoprim; systemic

3.8

52.5

246

725

XKD06

NOMESCO Finland

Physiologic investigation of micturition

10.8

51.7

102

100

R33

ICD-10 Finland

Retention of urine

4.6

51.6

192

456

SPAT1262

SPAT

Handing over of treatment supplies

2.5

47.6

447

2095

XKC03

NOMESCO Finland

Water cystometry

14.6

47.5

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

47.5

555

2911

G04BD12

ATC

mirabegron; oral

3.8

40.4

185

530

N02AX02

ATC

tramadol; systemic, rectal

2.0

40.0

809

5275

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

16.0

39.8

C61

ICD-10 Finland

Malignant neoplasm of prostate

2.6

39.0

324

1402

R35

ICD-10 Finland

Polyuria

4.1

38.9

160

417

N02BE01

ATC

paracetamol; systemic, rectal

2.2

38.2

1435

11759

UJF32

NOMESCO Finland

Coloscopy

2.2

38.0

469

2477

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2.6

37.6

310

1334

N03AX16

ATC

pregabalin; oral

2.3

37.4

413

2066

G04CB02

ATC

dutasteride; oral

3.7

37.4

172

494

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

6.0

36.6

104

181

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

36.6

840

5672

N06AX11

ATC

mirtazapine; oral

2.1

35.8

501

2781

SPAT1263

SPAT

Sampling

1.9

35.4

704

4496

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.9

35.3

243

935

G04BX05

ATC

10.8

34.5

KGH20

NOMESCO Finland

Correction of induration or curvature of penis

+∞

34.5

N03AX12

ATC

gabapentin; oral

2.6

33.9

282

1212

G04BD08

ATC

solifenacin; oral

4.6

33.4

121

278

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.9

33.3

742

4904

N39.3

ICD-10 Finland

Stress incontinence

14.9

32.9

N06AB04

ATC

citalopram; systemic

2.3

32.5

337

1624

WX320

NOMESCO Finland

Spinalanesthesy

2.2

31.8

360

1807

R07.4

ICD-10 Finland

Chest pain, unspecified

2.0

31.7

484

2765

A10AE04

ATC

insulin glargine; parenteral

2.6

31.5

263

1132

SPAT1153

SPAT

Removal of sutures

1.9

31.3

584

3602

J01MA12

ATC

levofloxacin; systemic

2.2

31.1

376

1944

G47.3

ICD-10 Finland

Sleep apnoea

2.0

30.7

502

2940

R31

ICD-10 Finland

Unspecified haematuria

2.7

30.7

225

896

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

8.1

30.5

G04BE04

ATC

yohimbine; oral

9.3

30.5

J01DB01

ATC

cefalexin; oral

1.9

30.5

1378

11415

A02BC02

ATC

pantoprazole; systemic

1.8

30.0

1056

8014

F52.2

ICD-10 Finland

Failure of genital response

6.1

30.0

144

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.8

29.9

207

797

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

28.9

554

3425

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

28.5

362

1904

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

28.4

494

2944

B01AB05

ATC

enoxaparin; parenteral

1.9

28.4

511

3085

E29.1

ICD-10 Finland

Testicular hypofunction

6.3

28.3

127

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

27.8

443

2552

KED52

NOMESCO Finland

Visual laser resection of prostate

147.3

27.7

S18

ICPC

Laceration/cut

1.8

27.5

739

5097

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.9

27.5

484

2892

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.8

27.5

193

748

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

4.0

27.0

114

303

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

2.8

27.0

186

712

N43.4

ICD-10 Finland

Spermatocele

13.9

26.8

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

26.4

336

1762

N06AX21

ATC

duloxetine; oral

2.9

26.3

169

617

M79.6

ICD-10 Finland

Pain in limb

1.9

26.3

516

3198

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.6

26.2

122

353

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.1

26.2

156

543

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

4.7

26.2

201

G04BE30

ATC

drugs used in erectile dysfunction - combinations

19.9

26.1

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

26.1

765

5391

N41.1

ICD-10 Finland

Chronic prostatitis

7.0

26.0

T89

ICPC

Diabetes insulin dependent

3.8

25.8

115

321

U05

ICPC

Urination problems other

4.5

25.6

215

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.5

25.5

210

892

WX110

NOMESCO Finland

Local anesthesy

1.7

25.5

1107

8741

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

25.1

325

1714

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.7

25.0

181

713

XKD03

NOMESCO Finland

Urethral pressure profilometry

13.3

24.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.0

24.7

394

2259

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.8

24.5

504

3160

SPAT1301

SPAT

No procedures

1.8

24.4

515

3255

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

2.5

24.3

199

840

7569

FHL

Other measure in this category

+∞

24.0

KGV40

NOMESCO Finland

Revision of penile prosthesis

+∞

24.0

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

+∞

24.0

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

23.8

618

4166

H3603, E103

ICD-10 Finland

7.6

23.7

L17

ICPC

Foot/toe symptom/complaint

1.9

23.6

384

2211

N02AJ06

ATC

codeine and paracetamol; systemic

1.7

23.3

621

4212

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

3.7

23.3

105

296

N48.6

ICD-10 Finland

Induratio penis plastica

54.8

23.1

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

23.1

514

3295

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

23.0

1021

7991

M54.5

ICD-10 Finland

Low back pain

1.8

22.6

471

2952

ZXA10

NOMESCO Finland

Bilateral

2.1

22.6

294

1549

AA1AD

NOMESCO Finland

CT of head and brain

1.8

22.4

431

2625

103

Kela drug reimbursment

Diabetes, insulin-treated

1.7

22.2

556

3687

N05BA04

ATC

oxazepam; oral

2.0

22.1

340

1910

V03AX01

ATC

[D]nalfurafine; oral

6.6

22.0

N06AX16

ATC

venlafaxine; oral

2.4

21.9

198

879

A06AD11

ATC

lactulose; oral

2.2

21.8

238

1157

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

21.8

766

5594

C10AA05

ATC

atorvastatin; oral

1.7

21.7

752

5466

A02BC05

ATC

esomeprazole; systemic

1.7

21.5

595

4056

A10AA02

ATC

3.5

21.3

101

297

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

21.3

266

1373

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

21.2

367

2148

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.0

21.1

130

460

TKC22

NOMESCO Finland

Catheterisation instruction

6.7

21.1

N05CF01

ATC

zopiclone; oral

1.8

20.9

480

3088

60500

ICD-8 Finland

Redundant prepuce and phimosis, Phimosis

+∞

20.9

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.9

20.7

382

2288

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

4.6

20.4

162

R51.80

ICD-10 Finland

Headache

2.4

20.4

181

796

A10AA01

ATC

3.9

20.3

225

N43.3

ICD-10 Finland

Hydrocele, unspecified

13.2

20.2

N46

ICD-10 Finland

Male infertility

48.6

20.2

N48.1

ICD-10 Finland

Balanoposthitis

5.1

20.0

130

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.7

20.0

142

553

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

20.0

142

553

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.4

19.9

177

777

L03

ICPC

Low back symptom/complaint

1.9

19.9

319

1814

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

9.7

19.9

KFD20

NOMESCO Finland

Excision of hydrocele of testis

74.3

19.7

T90

ICPC

Diabetes non-insulin dependent

1.7

19.7

462

2982

TPH07

NOMESCO Finland

Cathetrisation of artery

2.2

19.7

218

1068

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.4

19.6

296

G03BB01

ATC

mesterolone; oral

7.5

19.5

N06AB10

ATC

escitalopram; oral

2.0

19.4

259

1372

WX704

NOMESCO Finland

Intubation

2.6

19.3

142

564

JN3AD

NOMESCO Finland

Abdominal CT examination

2.5

19.1

155

648

J01FF01

ATC

clindamycin; systemic

1.7

19.0

464

3028

XF402

NOMESCO Finland

ECG with work load test

2.1

18.9

227

1151

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

18.8

241

1254

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

18.8

203

982

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

8.1

18.8

R06.0

ICD-10 Finland

Dyspnoea

1.8

18.6

375

2304

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

12.4

18.6

A02BC03

ATC

lansoprazole; oral

1.7

18.6

430

2759

G04BD07

ATC

tolterodine; oral

4.3

18.4

161

SPAT1260

SPAT

Consultation of another employee

1.9

18.3

286

1607

SPAT1310

SPAT

Counselling related to known health issue

1.7

18.0

475

3162

KDV10

NOMESCO Finland

Internal urethrotomy

13.1

17.9

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

17.9

477

3185

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

17.9

1054

8596

M48.0

ICD-10 Finland

Spinal stenosis

2.1

17.8

207

1035

H3600, E103

ICD-10 Finland

6.7

17.7

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

17.7

403

2570

A02BC01

ATC

omeprazole; systemic

1.7

17.6

413

2652

C07AB07

ATC

bisoprolol; oral

1.6

17.5

816

6284

TKC20

NOMESCO Finland

Catheterisation of bladder

2.5

17.3

139

580

J01MA01

ATC

ofloxacin; systemic

2.4

17.3

151

659

C08CA01

ATC

amlodipine; oral

1.6

17.2

638

4637

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

17.2

790

6050

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

7.0

17.2

J01CA04

ATC

amoxicillin; systemic

1.6

17.0

1228

10446

R03AC02

ATC

salbutamol; inhalant

1.6

17.0

725

5454

N03AE01

ATC

clonazepam; systemic

2.9

16.9

106

380

N05BA01

ATC

diazepam; systemic, rectal

2.1

16.9

208

1063

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.3

16.8

156

702

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

16.7

920

7328

A10AE05

ATC

insulin detemir; parenteral

2.5

16.7

135

565

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

4.3

16.7

148

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

16.5

1452

12929

R52.9

ICD-10 Finland

Pain, unspecified

2.6

16.5

128

524

PD2AE

NOMESCO Finland

Ultrasound examination of outer genitals

171.5

16.5

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

4.2

16.4

155

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

16.3

836

6539

K02.1

ICD-10 Finland

Caries of dentine

1.5

16.3

867

6840

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

11.3

16.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

16.2

450

3025

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

8.5

16.2

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

16.1

465

3155

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

16.0

349

2183

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

7.5

15.9

C03CA01

ATC

furosemide; systemic

1.6

15.9

467

3187

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.8

15.9

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

15.8

339

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

15.7

611

4466

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

2.3

15.7

155

718

7563

FHL

Placing an impotence prosthesis

+∞

15.6

KGH30

NOMESCO Finland

Resection or ligature of penile vein

+∞

15.6

E10

ICD-10 Finland

Type 1 diabetes mellitus

4.5

15.6

125

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.8

15.6

178

Y08

ICPC

Sexual function sympt/compl male

11.8

15.6

A28

ICPC

Limited function/disability NOS

1.9

15.5

229

1257

J01CA08

ATC

pivmecillinam; oral

3.0

15.4

299

N06AB03

ATC

fluoxetine; oral

2.1

15.3

174

858

WX720

NOMESCO Finland

Own respiration

3.1

15.2

279

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

15.1

414

2765

R05

ICPC

Cough

1.8

15.1

284

1697

G04BD11

ATC

fesoterodine; oral

5.2

15.0

A11

ICPC

Chest pain NOS

2.5

14.9

124

527

127

Kela drug reimbursment

Transplant complication

4.5

14.9

117

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.2

14.9

160

771

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

14.9

177

890

R39.1

ICD-10 Finland

Other difficulties with micturition

3.7

14.8

181

N39.4

ICD-10 Finland

Other specified urinary incontinence

3.9

14.8

156

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

14.8

142

649

N41.0

ICD-10 Finland

Acute prostatitis

5.0

14.8

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

14.8

702

5360

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

14.7

197

1041

Y07

ICPC

Impotence NOS

7.5

14.7

WX402

NOMESCO Finland

General anaesthesia

1.8

14.6

263

1548

U02

ICPC

Urinary frequency/urgency

2.7

14.5

377

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

14.5

132

587

N43.0

ICD-10 Finland

Encysted hydrocele

151.1

14.5

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.7

14.4

175

SPAT1097

SPAT

Recording of ECG

1.8

14.4

248

1437

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

14.3

848

6772

WX725

NOMESCO Finland

Noninvasive ventilation

2.7

14.3

369

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

14.2

540

3908

R01AD09

ATC

mometasone; nasal

1.5

14.2

571

4186

205

Kela drug reimbursment

Chronic hypertension

1.6

14.2

519

3720

R02

ICPC

Shortness of breath/dyspnoea

2.1

14.1

172

875

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

5.3

14.1

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.8

14.0

258

1525

L04AA06

ATC

mycophenolic acid; systemic

4.4

14.0

116

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

6.2

14.0

Z94.0

ICD-10 Finland

Kidney transplant status

5.6

13.9

N06AX12

ATC

bupropion; oral

2.9

13.9

309

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.9

13.9

295

SPAT1312

SPAT

General health counselling

1.6

13.8

446

3101

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.3

13.7

125

558

N06AA09

ATC

amitriptyline; systemic

2.3

13.7

132

604

A02BA02

ATC

ranitidine; systemic

1.7

13.7

284

1745

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

13.6

330

2121

KG1AE

NOMESCO Finland

Ultrasound examination of penis

+∞

13.6

N48.3

ICD-10 Finland

Priapism

+∞

13.6

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.3

13.5

124

555

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

13.5

297

KMAK

NOMESCO Finland

1.5

13.4

738

5772

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

13.4

232

1346

SPAT1325

SPAT

Vaccination

1.5

13.3

500

3597

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

8.2

13.3

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.1

13.3

237

Y06

ICPC

Prostate symptom/complaint

3.0

13.2

272

C09CA01

ATC

losartan; oral

1.6

13.1

387

2620

J01DA01

ATC

[U] cefalexin; systemic

1.5

13.1

921

7562

R01AD08

ATC

fluticasone; nasal

1.6

13.1

360

2396

M03BX01

ATC

baclofen; systemic

4.8

13.1

N30.0

ICD-10 Finland

Acute cystitis

2.8

13.0

307

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

13.0

163

838

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

12.9

247

1478

N06AB06

ATC

sertraline; oral

2.2

12.8

136

651

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

12.8

574

4289

U07

ICPC

Urine symptom/complaint other

3.0

12.8

261

P20

ICPC

Memory disturbance

2.0

12.8

172

910

C01DA14

ATC

isosorbide mononitrate; oral

1.7

12.6

284

1787

J01AA02

ATC

doxycycline; systemic

1.5

12.6

1189

10312

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

12.6

115

515

C10AA01

ATC

simvastatin; oral

1.5

12.5

764

6079

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

12.5

618

4713

A10AE06

ATC

insulin degludec; parenteral

3.0

12.5

240

Z01.2

ICD-10 Finland

Dental examination

1.5

12.5

544

4037

A03AD01

ATC

papaverine; systemic (papaverine and derivatives)

13.3

12.4

UDC00

NOMESCO Finland

Ear microscopy

2.3

12.4

119

545

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

12.4

101

424

U01

ICPC

Dysuria/painful urination

3.8

12.4

136

H25.1

ICD-10 Finland

Senile nuclear cataract

1.6

12.3

335

2218

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

12.3

304

1960

KDE20

NOMESCO Finland

Removal of foreign body from urethra

7.2

12.3

N06AG02

ATC

moclobemide; oral

2.7

12.3

310

N32.0

ICD-10 Finland

Bladder-neck obstruction

8.5

12.3

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

12.2

113

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

12.2

415

2909

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

12.1

134

655

KED33

NOMESCO Finland

Transurethral incision of prostate

7.8

12.1

H3601, E103

ICD-10 Finland

4.8

12.1

ZXC96

NOMESCO Finland

Robot assisted procedure

3.0

12.1

235

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

12.0

109

486

AN1

Coronary angiography

1.7

12.0

252

1552

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.1

11.9

216

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

11.9

117

540

7451

FHL

Transurethral adenoma removal

47.0

11.9

H04AA01

ATC

glucagon; nasal, parenteral

3.4

11.9

167

M25.5

ICD-10 Finland

Pain in joint

1.6

11.8

343

2306

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.3

11.8

107

476

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

11.8

387

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

11.8

201

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.8

11.8

232

1401

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

11.7

173

946

D01

ICPC

Abdominal pain/cramps general

2.2

11.7

118

551

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.3

11.7

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.3

11.7

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

11.6

364

U29

ICPC

Urinary symptom/complaint other

4.4

11.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

11.6

383

2662

H04.10

ICD-10 Finland

Dry eye syndrome

2.3

11.6

108

489

C07AA05

ATC

propranolol; systemic

1.8

11.6

218

1295

D06

ICPC

Abdominal pain localized other

2.5

11.5

370

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

11.5

115

538

N48.0

ICD-10 Finland

Leukoplakia of penis

+∞

11.5

KGV50

NOMESCO Finland

Removal of penile prosthesis

+∞

11.5

U08

ICPC

Urinary retention

4.6

11.5

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.2

11.5

194

R42

ICD-10 Finland

Dizziness and giddiness

1.7

11.4

271

1725

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.1

11.4

128

628

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

11.4

370

2559

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

6.1

11.4

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.9

11.3

174

967

N30.9

ICD-10 Finland

Cystitis, unspecified

3.8

11.3

127

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.7

11.2

133

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.5

11.2

455

3313

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

11.2

320

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

12.8

11.1

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

4.9

11.1

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.9

11.1

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

11.0

312

2082

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

11.0

446

3241

ZXA00

NOMESCO Finland

Right side

1.5

10.9

388

2736

P01AB01

ATC

metronidazole; oral, rectal

1.5

10.9

464

3407

S29

ICPC

Skin symptom/complaint other

1.7

10.9

230

1417

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

10.8

186

1072

H13

ICPC

Plugged feeling ear

1.6

10.8

279

1819

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.6

10.8

270

1746

H3603, E113

ICD-10 Finland

5.1

10.8

G44.2

ICD-10 Finland

Tension-type headache

2.1

10.8

130

657

R53

ICD-10 Finland

Malaise and fatigue

1.7

10.8

239

1494

SDA02

NOMESCO Finland

Parodonthologic therapy

1.5

10.8

422

3043

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

10.7

216

1310

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

10.7

224

1375

N06AX03

ATC

mianserin; oral

2.6

10.7

317

H43.1

ICD-10 Finland

Vitreous haemorrhage

3.2

10.7

176

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

10.7

328

2235

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

10.7

207

1243

P06

ICPC

Sleep disturbance

2.0

10.6

134

692

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.7

10.6

B01AC04

ATC

clopidogrel; oral

1.6

10.6

313

2110

R32

ICD-10 Finland

Unspecified urinary incontinence

5.3

10.6

R09.1

ICD-10 Finland

Pleurisy

5.5

10.6

J02AC01

ATC

fluconazole; systemic

1.6

10.6

275

1795

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

10.6

125

630

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

10.6

206

1237

R11

ICD-10 Finland

Nausea and vomiting

2.4

10.4

373

ZX137

NOMESCO Finland

To penis

+∞

10.4

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.8

10.4

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

10.4

483

3605

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

10.3

170

968

D12

ICPC

Constipation

3.3

10.3

154

G04BD04

ATC

oxybutynin; oral, transdermal

3.2

10.3

165

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.7

10.2

200

1202

S20

ICPC

Corn/callosity

3.5

10.2

133

N02AA05

ATC

oxycodone; systemic

1.7

10.2

230

1441

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

10.2

222

1377

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.2

10.2

L12

ICPC

Hand/finger symptom/complaint

1.8

10.2

172

989

M01AB05

ATC

diclofenac; systemic, rectal

1.4

10.1

1008

8638

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.0

10.1

128

662

R49.08

ICD-10 Finland

Other specified dysphonia

4.7

10.1

E0000UV

ATC

1.5

10.1

493

3714

SPAT1211

SPAT

Application of soft bandage

2.0

10.1

129

668

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

3.5

10.1

135

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

10.1

613

4816

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.2

10.1

454

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

10.0

139

744

A01

ICPC

Pain general/multiple sites

2.3

10.0

434

R52.2

ICD-10 Finland

Other chronic pain

3.4

10.0

141

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

10.0

355

2499

SPAT1240

SPAT

Therapeutic discussion

2.1

10.0

120

606

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

10.0

316

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.5

10.0

298

TK800

NOMESCO Finland

Hemodialysis

2.9

9.9

215

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.1

9.9

115

572

ZXA05

NOMESCO Finland

Left side

1.5

9.9

359

2539

M03BX02

ATC

tizanidine; oral

1.4

9.9

871

7295

R01AD12

ATC

fluticasone furoate; nasal

1.5

9.9

333

2313

A11CC03

ATC

alfacalcidol; systemic

3.0

9.8

182

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

9.8

204

1252

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

9.8

452

3367

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

9.6

9.8

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.7

9.7

253

-1

NOMESCO Finland

1.5

9.7

430

3168

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

9.7

135

724

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

9.7

235

1505

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

5.2

9.7

C07AB02

ATC

metoprolol; systemic

1.6

9.7

306

2092

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

9.7

178

1050

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

5.3

9.7

7542

FHL

Circumcisio

55.3

9.6

N05BA12

ATC

alprazolam; oral

2.0

9.6

128

674

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

9.6

198

1210

N03AX09

ATC

lamotrigine; oral

2.7

9.6

249

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.5

9.6

365

2609

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

9.6

470

H36.01

ICD-10 Finland

Diabetic maculopathy

4.0

9.5

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

9.1

9.5

TKC52

NOMESCO Finland

Patient education concerning pelvic floor contraction exercises

10.1

9.5

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

9.5

135

730

R06.5

ICD-10 Finland

Mouth breathing

1.8

9.5

166

964

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

9.5

193

1175

WZC30

NOMESCO Finland

Teaching

1.7

9.4

212

1327

KFD30

NOMESCO Finland

Operation for spermatocele

30.2

9.4

M01AC06

ATC

meloxicam; systemic, rectal

1.4

9.4

461

3469

N48.9

ICD-10 Finland

Disorder of penis, unspecified

17.6

9.4

137

Kela drug reimbursment

Uraemia requiring dialysis

5.2

9.4

6050A

ICD-9 Finland

Redundant prepuce and phimosis[PHIMOSIS]

+∞

9.4

I95.1

ICD-10 Finland

Orthostatic hypotension

2.9

9.4

187

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.2

9.4

435

R05

ICD-10 Finland

Cough

1.6

9.3

233

1503

L05

ICPC

Flank/axilla symptom/complaint

2.3

9.3

360

L01

ICPC

Neck symptom/complaint

1.9

9.3

143

794

WX400

NOMESCO Finland

Inhalation anesthesy

2.8

9.3

217

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.8

9.3

217

N05AH04

ATC

quetiapine; oral

1.7

9.3

211

1326

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.8

9.3

154

879

A03FA02

ATC

cisapride; oral, rectal

2.3

9.3

395

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

6.5

9.3

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

9.2

1058

9212

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.6

9.2

294

2013

121

Kela drug reimbursment

Severe hypofunction of sexual glands

6.1

9.2

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

9.2

267

1790

P03

ICPC

Feeling depressed

2.2

9.1

400

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.1

9.1

482

WX002

NOMESCO Finland

Sedation and analgesia

1.6

9.1

283

1928

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

9.1

244

1603

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

9.1

371

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

9.0

374

N06AX26

ATC

vortioxetine; oral

2.5

9.0

276

C10AA07

ATC

rosuvastatin; oral

1.5

9.0

384

2803

WX780

NOMESCO Finland

Remote monitoring CPAP

2.2

9.0

396

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

9.0

135

746

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.8

9.0

194

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

9.0

218

1394

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

8.9

325

2294

M01AH01

ATC

celecoxib; oral (coxibs)

1.7

8.9

210

1333

J01FA09

ATC

clarithromycin; systemic

1.5

8.9

398

2933

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

5.8

8.9

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.4

8.9

329

S97

ICPC

Chronic ulcer skin

2.1

8.9

474

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.5

8.9

273

L28

ICPC

Limited function/disability (L)

1.7

8.9

189

1167

J01AA07

ATC

tetracycline; systemic

1.7

8.9

169

1008

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

8.8

313

2196

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

8.8

244

1616

N04BC05

ATC

pramipexole; oral

2.1

8.8

467

N05CF02

ATC

zolpidem; oral

1.7

8.8

206

1306

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

8.8

109

559

N35.9

ICD-10 Finland

Urethral stricture, unspecified

4.6

8.8

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

5.2

8.8

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.0

8.8

171

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

3.2

8.8

140

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.8

8.7

201

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

8.7

170

1022

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.6

8.7

103

U71

ICPC

Cystitis/urinary infection other

4.4

8.7

L82

ICD-10 Finland

Seborrhoeic keratosis

1.7

8.7

188

1165

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

8.7

448

L13

ICPC

Hip symptom/complaint

1.7

8.7

168

1007

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

8.7

479

3676

L04AD01

ATC

ciclosporin; systemic

3.5

8.7

114

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

8.7

126

686

CKC12

NOMESCO Finland

Photocoagulation of retina

2.2

8.7

382

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

4.3

8.6

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

8.6

405

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

8.6

407

3032

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

8.6

342

N18.8

ICD-10 Finland

Other chronic renal failure

2.5

8.6

264

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

8.6

183

1129

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

4.8

8.5

CJB10

NOMESCO Finland

Laser discission of secondary cataract

2.1

8.5

460

K59.0

ICD-10 Finland

Constipation

2.4

8.5

294

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

8.5

212

1365

A10BA02

ATC

metformin; oral

1.4

8.4

485

3746

A04

ICPC

Weakness/tiredness general

1.8

8.4

139

792

R07.3

ICD-10 Finland

Other chest pain

1.9

8.4

126

695

C10AA03

ATC

pravastatin; oral

1.9

8.4

118

634

SPAT1255

SPAT

Intravenous administration of medicine

2.0

8.4

110

576

K02

ICPC

Pressure/tightness of heart

3.3

8.4

123

N06AB05

ATC

paroxetine; oral

2.2

8.4

375

S10

ICPC

Boil/carbuncle

2.2

8.3

397

6030A

ICD-9 Finland

Hydrocele, Encysted hydrocele

+∞

8.3

M54.2

ICD-10 Finland

Cervicalgia

2.1

8.3

446

Z49.2

ICD-10 Finland

Other dialysis

5.3

8.3

H02AB04

ATC

methylprednisolone; systemic

1.7

8.2

178

1104

SPAT1229

SPAT

Assessment of need for aid

2.0

8.2

105

549

R55

ICD-10 Finland

Syncope and collapse

1.7

8.2

158

948

U04

ICPC

Incontinence urine

2.9

8.2

170

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

8.2

340

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

8.1

104

540

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

8.1

578

4626

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

8.1

110

583

C09AA05

ATC

ramipril; oral

1.4

8.1

422

3198

D11

ICPC

Diarrhoea

1.9

8.1

118

644

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

2.7

8.1

201

C05AA08

ATC

fluocortolone; rectal, topical

1.6

8.1

191

1210

KED76

NOMESCO Finland

TUVP

33.5

8.1

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.7

8.1

152

906

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

8.0

212

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

9.0

8.0

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

10.1

8.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

8.0

384

2865

L04AA01

ATC

[U] ciclosporin; systemic

4.0

8.0

C08CA13

ATC

lercanidipine; oral

1.6

8.0

196

1259

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.1

7.9

398

C10AX09

ATC

ezetimibe; oral

1.6

7.9

208

1358

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.4

7.9

SPAT1281

SPAT

Other administrative function

1.9

7.9

111

600

R21

ICPC

Throat symptom/complaint

1.7

7.9

175

1091

C03AA03

ATC

hydrochlorothiazide; oral

1.8

7.9

129

732

N99.1

ICD-10 Finland

Postprocedural urethral stricture

7.8

7.9

L15

ICPC

Knee symptom/complaint

1.6

7.9

235

1584

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.3

7.9

113

R50.9

ICD-10 Finland

Fever, unspecified

1.6

7.8

201

1306

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

5.7

7.8

J37.0

ICD-10 Finland

Chronic laryngitis

2.8

7.8

176

F29

ICPC

Eye symptom/complaint other

2.0

7.8

470

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

4.2

7.8

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.5

7.8

M01AE02

ATC

naproxen; oral, rectal

1.3

7.8

749

6276

A98

ICPC

Health maint/preventive medicine

1.5

7.8

1566

14768

KEB00

NOMESCO Finland

Biopsy of prostate

3.9

7.8

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.5

7.8

L16

ICPC

Ankle symptom/complaint

1.9

7.7

117

648

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

2.8

7.7

180

B01AA03

ATC

warfarin; systemic

1.4

7.7

345

2538

H02AB06

ATC

prednisolone; systemic

1.3

7.7

660

5431

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

7.7

103

545

KDG43

NOMESCO Finland

Transobturatorial sling urethrocystopexy

15.1

7.7

B02AA02

ATC

tranexamic acid; systemic

2.3

7.7

297

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

7.7

142

841

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

5.6

7.7

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

7.7

143

846

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

2.2

7.6

335

N06AB08

ATC

fluvoxamine; oral

2.9

7.6

154

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.1

7.6

393

-50

ICPC

Medication/prescr/renewal

2.3

7.6

292

116

Kela drug reimbursment

Prostate cancer

1.8

7.6

132

767

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.3

7.6

111

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

11.9

7.6

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

7.6

119

667

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.0

7.5

436

N03AF01

ATC

carbamazepine; oral, rectal

2.1

7.5

399

SPAT1254

SPAT

Administration of medicine

1.6

7.5

190

1230

SPAT1317

SPAT

Planned health check-up monitoring, health check-up performed based on individual need

2.2

7.5

332

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

3.3

7.5

107

WX723

NOMESCO Finland

CPAP therapy

2.2

7.5

321

R13

ICD-10 Finland

Dysphagia

2.0

7.4

468

TKF60

NOMESCO Finland

Puncture of scrotum

80.4

7.4

7503

FHL

Hydrosel or funicular surgery

80.4

7.4

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

7.4

497

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.0

7.4

141

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.4

7.4

242

F51.0

ICD-10 Finland

Nonorganic insomnia

1.8

7.4

129

751

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

3.4

7.4

C08CA02

ATC

felodipine; oral

1.7

7.4

151

922

H26.4

ICD-10 Finland

After-cataract

1.9

7.4

101

542

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.0

7.4

433

N06AX05

ATC

trazodone; oral

3.3

7.4

108

N17

ICPC

Vertigo/dizziness

1.8

7.3

117

659

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.7

7.3

183

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

7.3

151

924

C10AC01

ATC

colestyramine; oral

3.2

7.3

115

VALMI

NOMESCO Finland

1.5

7.2

289

2077

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.5

7.2

221

C07AG02

ATC

carvedilol; oral

1.9

7.2

105

574

R60.0

ICD-10 Finland

Localized oedema

1.7

7.2

139

832

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

7.2

121

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.7

7.2

142

857

H81

ICPC

Excessive ear wax

1.5

7.2

254

1776

M43.1

ICD-10 Finland

Spondylolisthesis

2.6

7.2

186

G82.1

ICD-10 Finland

Spastic paraplegia

30.1

7.1

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

7.1

411

P76

ICPC

Depressive disorder

2.3

7.1

273

M01AH02

ATC

rofecoxib; oral

1.7

7.1

158

987

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

7.1

375

N01

ICPC

Headache

2.1

7.1

389

R96

ICPC

Asthma

1.9

7.1

497

G04BD09

ATC

trospium; oral

4.0

7.1

K07.60

ICD-10 Finland

Snapping jaw

3.3

7.1

101

ZX136

NOMESCO Finland

Intravesicalis

5.6

7.1

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

7.1

276

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.7

7.1

129

761

Y28

ICPC

Limited function/disability (Y)

4.7

7.0

J01FA10

ATC

azithromycin; systemic

1.3

7.0

699

5861

WX290

NOMESCO Finland

Other blockade of nerve

1.3

7.0

587

4795

D82

ICPC

Teeth/gum disease

1.4

7.0

431

3355

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.0

7.0

434

SFA00

NOMESCO Finland

Small filling

1.6

7.0

171

1097

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.0

7.0

448

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

2.2

7.0

291

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

5.2

6.9

XX3DW

NOMESCO Finland

Time consuming IT work

1.7

6.9

156

978

A10BB12

ATC

glimepiride; oral

1.7

6.9

133

798

L08

ICPC

Shoulder symptom/complaint

1.5

6.9

244

1708

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

2.9

6.9

141

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

7.6

6.9

B05DA

ATC

Isotonic solutions

4.6

6.9

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.0

6.9

454

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.5

6.9

248

1743

SPAT1053

SPAT

Memory test

1.5

6.9

207

1399

R4180

NOMESCO Finland

Podiatric therapy

3.9

6.9

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

3.9

6.9

1530

FHL

Urethrocystoscopy

3.8

6.9

S01EE01

ATC

latanoprost; ophthalmic

2.0

6.8

405

M01AX17

ATC

nimesulide; oral

1.4

6.8

306

2246

R03BA05

ATC

fluticasone; inhalant

1.6

6.8

202

1357

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.3

6.8

255

L29.9

ICD-10 Finland

Pruritus, unspecified

3.4

6.8

S82

ICPC

Naevus/mole

1.7

6.8

134

811

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

3.0

6.8

121

PE1AT

NOMESCO Finland

Femoral artery PTA

3.6

6.8

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

6.8

153

962

A02BA04

ATC

nizatidine; systemic

1.9

6.8

538

WX240

NOMESCO Finland

Penis blockade

40.2

6.8

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.1

6.8

372

EBA00

NOMESCO Finland

Extraction of tooth

1.3

6.7

485

3871

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

4.7

6.7

H53.1

ICD-10 Finland

Subjective visual disturbances

2.1

6.7

351

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

6.7

105

592

C02AC05

ATC

moxonidine; oral

2.0

6.7

402

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

6.7

430

D07AC01

ATC

betamethasone; topical

1.4

6.7

469

3725

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.4

6.7

360

2735

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.1

6.7

366

H01

ICPC

Ear pain/earache

1.9

6.7

548

SPAT1167

SPAT

Insertion of urinary catheter

2.6

6.7

187

A12AA04

ATC

calcium carbonate; oral

3.0

6.7

123

R99

ICPC

Respiratory disease other

3.0

6.7

123

SPAT1252

SPAT

Overall medication plan or its review

1.8

6.6

104

584

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.1

6.6

112

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

2.4

6.6

233

I20.09

ICD-10 Finland

Unstable angina

1.8

6.6

102

570

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.5

6.6

206

C09AA02

ATC

enalapril; systemic

1.4

6.6

329

2465

S21

ICPC

Skin texture symptom/complaint

1.6

6.6

157

999

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

6.6

384

R30.0

ICD-10 Finland

Dysuria

2.9

6.6

134

XQ848

NOMESCO Finland

Dermatological photography

2.8

6.6

141

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

6.6

165

1068

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

6.5

177

1167

F52.0

ICD-10 Finland

Lack or loss of sexual desire

10.1

6.5

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.4

6.5

209

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

6.5

110

632

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

6.5

124

741

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

6.5

108

618

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

4.0

6.5

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.5

6.5

184

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

3.1

6.5

103

P29

ICPC

Psychological sympt/compl other

2.3

6.4

250

F34.1

ICD-10 Finland

Dysthymia

2.7

6.4

160

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

6.4

344

Z00.0

ICD-10 Finland

General medical examination

1.5

6.4

238

1681

G35

ICD-10 Finland

Multiple sclerosis

4.7

6.4

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

2.4

6.4

224

N06AA04

ATC

clomipramine; systemic

3.6

6.4

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

6.4

116

684

H02.4

ICD-10 Finland

Ptosis of eyelid

2.8

6.4

138

I20.00

ICD-10 Finland

Unstable angina

2.2

6.4

289

SPF00

NOMESCO Finland

Repatation of teeth prosthesis

2.5

6.4

187

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.9

6.4

109

Kela drug reimbursment

Multiple sclerosis

6.6

6.3

E000006

ATC

2.1

6.3

338

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

6.3

161

1044

G04BE09

ATC

vardenafil; oral

8.2

6.3

Z97.8

ICD-10 Finland

Presence of other specified devices

8.2

6.3

B03XA02

ATC

darbepoetin alfa; parenteral

2.6

6.3

163

N18.0

ICD-10 Finland

End-stage renal disease

3.2

6.3

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

11.1

6.3

M54

ICD-10 Finland

Dorsalgia

1.7

6.3

127

772

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

2.8

6.3

133

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.8

6.3

133

KH1AD

NOMESCO Finland

CT of urinary organs

2.2

6.3

280

B05DB

ATC

Hypertonic solutions

4.6

6.3

R74

ICPC

Upper respiratory infection acute

1.4

6.3

262

1897

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

6.3

200

1367

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.1

6.3

100

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

3.1

6.3

100

KDK10

NOMESCO Finland

Implantation of artificial urinary sphincter around bulbar urethra

18.1

6.3

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

6.3

260

60300

ICD-8 Finland

Hydrocele, Tunicae vaginalis testis

+∞

6.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

6.2

331

2506

XF404

NOMESCO Finland

Ambulatory ECG

1.6

6.2

141

886

J01CF05

ATC

flucloxacillin; systemic

2.1

6.2

295

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

7.0

6.2

R30.9

ICD-10 Finland

Painful micturition, unspecified

7.0

6.2

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

6.2

371

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.5

6.2

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

6.2

517

N62

ICD-10 Finland

Hypertrophy of breast

3.3

6.2

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.6

6.2

139

870

ZXC50

NOMESCO Finland

Cryotherapy

2.5

6.2

176

M02AA07

ATC

piroxicam; topical

1.3

6.2

453

3614

L57.0

ICD-10 Finland

Actinic keratosis

1.7

6.2

126

770

E000001

ATC

1.5

6.2

235

1671

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

6.2

474

A10BJ06

ATC

semaglutide; parenteral

2.2

6.2

255

JAETT

NOMESCO Finland

5.4

6.1

A50

ICPC

General and Unspecified, Medication/prescr/renewal

2.3

6.1

235

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.3

6.1

235

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

6.1

338

J01MA06

ATC

norfloxacin; oral

1.8

6.1

103

593

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

6.1

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.6

6.1

I79.2*E10.5

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

12.6

6.1

F52.9

ICD-10 Finland

Unspecified sexual dysfunction, not caused by organic disorder or disease

12.6

6.1

NHQ40

NOMESCO Finland

Amputation of toe

2.6

6.1

154

H3600, E113

ICD-10 Finland

3.1

6.1

L19

ICPC

Muscle symptom/complaint NOS

2.9

6.1

114

J34.2

ICD-10 Finland

Deviated nasal septum

1.8

6.1

101

581

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

6.1

372

2884

SPAT1043

SPAT

Audiometry

1.6

6.1

141

893

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

6.0

147

941

R06AE07

ATC

cetirizine; oral

1.3

6.0

466

3748

A03CA02

ATC

clidinium and psycholeptics; oral

2.1

6.0

320

XFE00

NOMESCO Finland

Epicardial ultrasonography

2.3

6.0

219

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

6.0

369

2864

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3017446) Testosterone [Moles/volume] in Serum or Plasma

663

2329

3.77

156.60

2.9

2.2

nmol/l

13.9

13.5

0.68

586

2070

(3026008) Bacteria identified in Urine by Culture

613

2612

2.95

98.83

3.6

2.6

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

258

636

4.51

96.57

2.5

1.9

pmol/l

213.4

213.2

0.01

244

599

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

305

858

4.02

95.68

2.2

1.9

nmol/l

40.3

40.4

0.02

295

825

(3031040) Bacteria [#/volume] in Urine by Automated count

1306

8567

2.52

81.96

5.5

3.4

e6/l

32.3

1282.4

0.85

136

(3037467) Urinalysis macro (dipstick) panel - Urine

1396

9531

2.55

78.90

5.6

3.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1559

11420

2.68

72.48

6.2

4.2

ug/l

2.1

2.8

1.13

1395

10138

(3009214) Lutropin [Units/volume] in Serum or Plasma

179

429

4.49

68.84

1.6

1.4

u/l

5.2

5.3

0.05

141

352

(3013826) Glucose [Moles/volume] in Serum or Plasma

1342

9508

2.26

61.79

7.2

5.6

mmol/l

7.3

7.0

4.64

1276

9002

(3032080) INR in Blood by Coagulation assay

1081

7127

2.13

58.50

13.8

10.7

inr

1.3

2.92

330

1949

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1537

11820

2.31

53.56

10.1

8.2

u/l

78.9

80.1

0.43

1474

11196

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1104

7494

2.06

53.38

11.0

8.0

mmol/l

1.2

0.46

916

6359

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

860

5403

2.04

50.72

4.7

3.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1021

6822

2.02

50.60

9.2

7.2

mmol/l

1.2

0.62

939

6254

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1014

6850

1.98

47.72

5.4

4.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

997

6726

1.97

46.79

7.4

5.7

g/l

35.1

0.11

935

6273

(3000850) Epithelial cells [#/volume] in Urine

564

3107

2.14

46.65

3.6

2.5

e6/l

2.2

2.9

2.58

503

2718

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

771

4766

2.01

46.57

3.4

2.8

u/l

56.6

59.3

0.95

701

4478

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1136

8066

1.95

45.23

7.4

7.3

umol/l

12.3

13.2

1.25

1080

7731

(3021387) Prolactin [Units/volume] in Serum or Plasma

123

305

4.23

45.00

1.7

1.8

mu/l

243.4

294.1

1.18

110

292

(3009261) Glucose [Presence] in Urine by Test strip

991

6751

1.93

44.37

4.2

2.9

estimate

0.0

0.46

207

1105

(3035350) Ketones [Presence] in Urine by Test strip

984

6689

1.93

44.33

4.1

2.9

estimate

0.0

0.50

225

1163

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1313

9832

1.98

44.21

3.6

2.9

pmol/l

15.0

14.9

0.36

1185

8858

(3002582) Erythrocytes [#/volume] in Urine

742

4619

1.97

43.14

4.7

3.1

e6/l

51.5

126.5

1.28

628

3558

(3026782) Osmolality of Urine

531

2937

2.10

42.93

3.8

2.6

mosm/kgh2o

581.5

588.7

0.31

474

2508

(3018095) Leukocytes [#/volume] in Urine

799

5110

1.94

42.81

5.1

3.4

e6/l

62.1

66.6

0.12

653

3751

(3013707) Erythrocyte sedimentation rate by Westergren method

1405

10865

1.99

41.87

4.8

3.8

mm/h

11.6

12.2

0.71

1313

10046

(3009508) Creatinine [Moles/volume] in Urine

854

5623

1.91

41.57

4.2

3.3

mmol/l

8.3

8.7

1.52

727

4766

(3041096) Erythrocytes [Presence] in Urine by Automated

598

3503

2.01

41.02

3.9

2.7

—

(3047181) Lactate [Moles/volume] in Blood

172

570

3.21

40.91

5.0

7.4

mmol/l

1.4

0.08

147

509

(3012516) Albumin [Mass/volume] in Urine

826

5404

1.90

40.79

4.2

3.3

mg/l

664.5

261.1

1.37

613

3784

(3020682) Albumin/Creatinine [Ratio] in Urine

857

5678

1.89

40.67

5.5

4.1

mg/mmol

16.1

10.6

1.55

616

3926

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1601

13051

2.15

40.21

4.7

3.6

mu/l

1.9

2.2

1.19

1455

11801

(3021601) Nitrite [Presence] in Urine by Test strip

965

6671

1.87

39.81

5.5

3.9

estimate

0.0

0.00

229

1227

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1202

8970

1.86

38.13

5.5

3.6

21.5

22.7

1.59

558

3894

(3030467) Casts [#/volume] in Urine by Automated count

673

4215

1.90

37.21

4.5

3.0

e6/l

0.5

0.15

548

3153

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

652

4057

1.90

36.67

1.9

1.7

mmol/l

1.4

1.5

0.12

532

3397

(3018418) pH of Serum or Plasma

691

4389

1.88

36.41

6.7

4.6

7.4

0.19

160

846

(42870588) Differential panel, method unspecified - Blood

791

5249

1.84

36.20

7.0

6.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

807

5403

1.83

35.76

3.7

2.8

ug/l

191.2

209.8

0.67

751

5007

(3023368) Bacteria identified in Blood by Culture

737

4799

1.85

35.74

5.9

4.7

—

(3006504) Eosinophils/100 leukocytes in Blood

996

7126

1.79

35.18

7.2

6.4

2.9

3.0

0.08

944

6696

(3019069) Monocytes/100 leukocytes in Blood

999

7172

1.79

34.71

7.7

6.7

9.0

9.2

0.49

951

6761

(36304419) Bacteria [Presence] in Urine

645

4058

1.87

34.67

4.3

3.0

—

(3022096) Basophils/100 leukocytes in Blood

966

6938

1.76

32.89

7.2

6.4

0.6

0.7

0.76

916

6538

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

743

4968

1.79

32.21

2.6

2.2

u/l

377.5

300.6

0.35

700

4661

(3002030) Lymphocytes/100 leukocytes in Blood

1005

7335

1.75

32.03

7.5

6.5

25.9

26.3

0.58

948

6864

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1767

15389

2.31

31.31

23.4

15.3

mg/l

26.9

28.2

0.88

1491

12344

(3018572) Chloride [Moles/volume] in Blood

127

414

3.21

30.94

5.1

8.6

mmol/l

105.1

0.03

115

373

(3039000) Anion gap in Blood

127

414

3.21

30.94

5.1

8.6

mmol/l

11.1

11.5

0.79

115

373

(3018010) Neutrophils/100 leukocytes in Blood

987

7234

1.72

30.41

7.2

6.2

58.6

58.1

0.60

933

6816

(3001604) Monocytes [#/volume] in Blood

1027

7627

1.71

30.00

6.9

6.0

e9/l

0.6

0.04

916

6564

(3006315) Basophils [#/volume] in Blood

1030

7661

1.71

29.87

6.9

6.1

e9/l

0.0

0.57

925

6611

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

733

4971

1.75

29.66

2.6

2.1

nmol/l

76.5

74.0

1.53

667

4439

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

589

3757

1.81

29.37

2.3

2.1

mg/l

2.7

2.9

1.28

522

3225

(40761536) Microorganisms panel - Urine sediment

241

1118

2.31

29.35

5.0

3.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

871

6212

1.71

29.29

2.3

2.0

pmol/l

95.0

91.2

1.64

524

3614

(3013115) Eosinophils [#/volume] in Blood

1050

7891

1.70

28.95

7.3

6.3

e9/l

0.2

0.01

954

6908

(3013650) Neutrophils [#/volume] in Blood by Automated count

1137

8755

1.70

28.39

10.2

9.7

e9/l

4.4

0.32

1023

7600

(3019198) Lymphocytes [#/volume] in Blood

1040

7828

1.69

28.23

7.0

6.2

e9/l

1.9

0.04

943

6853

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1707

14812

2.06

28.21

8.6

6.1

mmol/mol

43.1

40.7

14.12

1599

13765

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

753

5207

1.72

28.02

4.4

3.0

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1824

16262

2.43

27.84

27.7

18.1

mmol/l

139.6

0.12

1782

15892

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

744

5175

1.70

26.79

4.0

3.6

u/l

38.0

41.9

0.33

698

4904

(40761511) CBC panel - Blood by Automated count

1808

16125

2.31

26.42

23.5

14.0

—

(3019309) Folate [Moles/volume] in Red Blood Cells

465

2841

1.83

26.29

1.9

1.7

nmol/l

1097.0

1134.0

0.42

365

2187

(3023103) Potassium [Moles/volume] in Serum or Plasma

1823

16326

2.37

26.18

28.2

18.3

mmol/l

4.1

4.0

4.20

1779

15932

(3002385) Erythrocyte distribution width [Ratio]

1512

12723

1.78

26.01

28.1

18.5

13.7

0.17

1476

12417

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

291

1541

2.04

25.17

4.4

2.9

ng/l

226.6

229.6

0.04

277

1412

(3042936) Bacteria identified in Isolate by Culture

411

2461

1.84

24.62

3.1

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

404

2412

1.85

24.41

1.4

1.2

u/ml

2.1

2.6

0.33

643

(3044889) 12 lead EKG panel

1382

11427

1.68

24.36

5.1

4.0

—

(3013512) EKG study

664

4570

1.68

24.35

4.8

4.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

432

2649

1.81

23.86

2.2

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

222

1082

2.18

23.82

9.5

12.6

—

(3049717) Cytology report of Urine Cyto stain

152

630

2.53

23.64

3.2

3.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

532

3480

1.72

23.40

1.7

1.6

nmol/l

20.1

19.2

0.65

488

3037

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

848

6275

1.61

22.95

4.6

3.6

ng/l

39.2

61.6

3.09

655

4679

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

490

3157

1.73

22.66

1.8

1.7

pmol/l

53571832.9

36818758.5

0.21

420

2659

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

514

3378

1.70

22.02

5.5

3.9

ng/l

453.9

577.9

0.44

433

2878

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1290

10609

1.61

21.94

4.1

3.3

u/l

60.7

61.7

0.09

1203

9914

(3007930) Methemoglobin/Hemoglobin.total in Blood

165

735

2.36

21.91

4.9

6.2

0.9

1.71

153

692

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

166

746

2.34

21.60

4.8

6.1

1.8

1.7

0.48

154

704

(3000494) Fungus identified in Specimen by Culture

316

1810

1.89

21.54

1.8

1.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

397

2442

1.78

21.46

4.1

2.7

g/l

2.2

0.05

374

2290

(3003396) Base excess in Arterial blood by calculation

365

2193

1.81

21.33

8.2

8.9

mmol/l

1.0

0.8

0.28

274

1720

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

195

943

2.18

21.27

7.0

4.9

ng/l

131.3

105.1

1.67

176

835

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

380

2317

1.79

21.13

4.1

2.8

23.0

23.7

0.45

300

2030

(3022948) Iron [Moles/volume] in Serum or Plasma

411

2570

1.75

20.94

4.0

2.7

umol/l

12.8

13.2

0.61

393

2427

(3044640) Blood type and Crossmatch panel - Blood

666

4741

1.61

20.60

3.1

2.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1841

16838

2.22

20.36

14.2

10.6

u/l

28.9

30.8

2.64

1782

16255

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

361

2198

1.78

20.08

8.4

8.9

kpa

5.1

0.06

343

2106

(3008152) Bicarbonate [Moles/volume] in Arterial blood

229

1207

2.01

19.86

6.0

7.8

mmol/l

24.3

0.06

211

1134

(3027801) Oxygen [Partial pressure] in Arterial blood

360

2198

1.78

19.81

8.4

8.9

kpa

12.1

0.07

342

2105

(3007853) Bacteria identified in Skin by Aerobe culture

329

1958

1.81

19.72

2.3

1.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

390

2459

1.73

19.12

4.0

2.9

e6/l

0.7

0.5

0.85

256

1364

(3016502) Oxygen saturation in Arterial blood

333

2015

1.78

18.82

8.6

9.3

95.3

95.5

0.17

317

1941

(3002256) Pathology report gross observation

292

1699

1.84

18.78

1.4

1.3

—

(3048689) Calprotectin [Mass/mass] in Stool

244

1349

1.92

18.37

2.4

2.6

ug/g

206.7

188.4

0.18

188

1113

(3002173) Hemoglobin [Mass/volume] in Arterial blood

309

1843

1.80

18.30

9.1

9.9

g/l

124.4

123.9

0.14

293

1786

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1731

15611

1.83

18.24

5.7

4.5

mmol/l

1.3

3.96

1605

14449

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

309

1845

1.80

18.23

2.2

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

309

1846

1.80

18.19

2.2

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1766

16042

1.89

17.94

6.4

5.0

mmol/l

2.4

2.6

16.24

1640

14860

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1738

15714

1.83

17.87

5.8

4.5

mmol/l

4.2

4.4

16.99

1618

14635

(40768804) Tissue Pathology biopsy report

706

5225

1.54

17.85

2.4

2.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

369

2343

1.71

17.49

11.7

7.1

mmol/l

1.1

1.0

2.98

342

2200

(3006184) Hemoglobin [Mass/volume] in Capillary blood

380

2.66

17.46

2.9

2.1

g/l

137.4

131.4

1.26

262

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

118

501

2.44

17.42

4.8

2.7

mg/l

1.8

1.6

1.56

110

459

(3029937) Albumin [Presence] in Urine by Test strip

529

3685

1.59

17.36

4.6

3.1

estimate

0.0

1.23

209

1095

(3007461) Platelets [#/volume] in Blood

1877

17461

2.29

17.22

33.9

21.8

e9/l

230.1

233.0

1.24

1842

16999

(3028626) Oxygen [Partial pressure] in Capillary blood

101

401

2.60

17.16

3.0

2.8

kpa

8.5

7.9

2.88

364

(3035941) MCH [Entitic mass]

1877

17465

2.28

17.14

33.7

21.7

30.5

30.6

2.06

1852

17212

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

204

1086

1.98

17.13

3.9

3.5

mmol/l

1.5

1.8

0.54

150

791

(3026361) Erythrocytes [#/volume] in Blood

1877

17468

2.28

17.08

33.9

21.8

e12/l

4.6

1.97

1837

16939

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1049

8490

1.50

17.07

2.6

2.4

—

(3024731) MCV [Entitic volume]

1877

17469

2.28

17.06

33.8

21.7

91.2

91.4

0.99

1852

17216

(3019060) Gas panel - Arterial blood

232

1292

1.90

17.05

4.6

5.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

400

2611

1.67

17.04

3.6

2.7

e6/l

0.8

1.0

0.56

262

1501

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

212

1146

1.95

17.03

3.9

3.5

kpa

5.1

5.2

0.25

202

1052

(3000963) Hemoglobin [Mass/volume] in Blood

1877

17472

2.28

17.00

34.1

21.9

g/l

139.0

140.7

4.53

1850

17215

(3010813) Leukocytes [#/volume] in Blood

1877

17474

2.27

16.97

33.9

21.8

e9/l

6.9

0.13

1837

16954

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1685

15161

1.72

16.81

5.8

4.6

mmol/l

6.4

6.2

5.82

1539

13850

(3018677) aPTT in Platelet poor plasma by Coagulation assay

430

2871

1.63

16.73

2.6

2.3

30.0

30.4

0.69

418

2795

(3009343) pH of Capillary blood

209

1132

1.95

16.68

4.0

3.5

7.4

0.11

127

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1684

15166

1.71

16.53

5.0

4.1

mmol/l

1.4

0.15

1547

13964

(3021589) Normoblasts [#/volume] in Blood

872

6838

1.49

16.33

13.9

9.9

e9/l

0.0

0.52

727

5602

(3015377) Calcium [Moles/volume] in Serum or Plasma

625

4588

1.53

16.02

3.9

3.7

mmol/l

2.3

1.90

543

4039

(3009542) Hematocrit [Volume Fraction] of Blood

1590

14159

1.61

15.77

24.8

16.3

40.3

41.0

1.86

1017

10124

(3020779) Urea [Moles/volume] in Serum or Plasma

297

1826

1.74

15.70

14.4

8.4

mmol/l

11.6

10.4

2.05

285

1745

(1616796) Gas panel - Central venous blood

401

2.52

15.66

5.3

4.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

5.42

15.43

2.7

1.3

nmol/l

0.1

0.27

(3023323) Follitropin [Units/volume] in Serum or Plasma

142

3.59

15.19

1.6

1.4

iu/l

8.5

8.9

0.08

114

(40767503) Oxygen content in Capillary blood by calculation

383

2.53

15.17

3.3

2.4

17.5

16.4

1.61

200

(3015235) Bicarbonate [Moles/volume] in Capillary blood

109

477

2.36

15.06

3.4

2.9

mmol/l

24.0

24.7

0.59

403

(3010375) cycloSPORINE [Mass/volume] in Blood

4.51

14.97

29.7

21.7

ug/l

143.2

124.0

0.42

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

455

3154

1.57

14.93

2.1

1.8

mg/l

1.6

1.5

0.36

354

2477

(3036481) Cortisol [Moles/volume] in Serum or Plasma

216

1231

1.85

14.71

2.1

2.5

nmol/l

351.6

373.5

1.07

203

1145

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

211

1198

1.85

14.54

6.9

4.8

mmol/l

1.2

0.92

184

1082

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

118

3.79

14.53

1.7

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

280

1731

1.72

14.45

4.8

3.4

—

(3021901) Oxygen saturation in Capillary blood

345

2.56

14.34

3.2

2.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

243

2.82

13.61

1.9

1.3

pmol/l

92.1

191.5

0.37

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

154

807

1.98

13.49

1.7

2.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

288

1826

1.67

13.48

3.0

3.2

umol/l

7.5

10.4

2.18

246

1641

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

144

737

2.03

13.48

1.7

1.9

—

(3022145) Colonoscopy Study observation

262

1634

1.69

13.03

1.5

1.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

629

4785

1.46

12.95

3.3

2.9

umol/l

3181.8

5387.2

0.77

547

4192

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

802

6387

1.43

12.88

3.3

2.5

ug/l

0.7

0.8

0.69

542

3943

(40768797) Stomach Pathology biopsy report

302

1961

1.64

12.85

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

274

1739

1.67

12.74

1.3

titre

442.9

379.0

0.19

320

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

189

1087

1.82

12.46

1.9

1.7

—

(3019150) Specific gravity of Urine by Refractometry

423

2990

1.53

12.45

4.0

3.1

kg/l

1.0

0.83

398

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

114

551

2.13

12.43

2.1

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

315

2089

1.60

12.27

2.1

1.7

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

633

4901

1.43

11.59

3.6

3.2

ng/l

1998.8

1641.6

0.61

543

4301

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

499

3699

1.47

11.52

3.0

2.7

—

(3022621) pH of Urine by Test strip

149

817

1.89

11.43

3.1

2.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

343

2365

1.54

11.21

1.6

g/l

2.7

2.9

1.32

211

1523

(43055514) Macroprolactin [Presence] in Serum or Plasma

10.97

11.07

1.3

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

3.62

10.92

1.4

1.2

nmol/l

1.1

1.2

0.34

(3037121) Protein [Mass/volume] in Urine

103

509

2.08

10.63

3.9

3.3

g/l

0.4

0.3

0.40

293

(3027945) Reticulocytes/100 erythrocytes in Blood

304

2069

1.55

10.50

2.7

2.4

1.8

0.15

271

1835

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

385

2.23

10.49

8.8

6.4

iu/ml

3089.8

7220.8

0.38

(36660697) Celiac disease serology panel - Serum

152

864

1.82

10.41

1.3

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

392

2.19

10.05

1.6

ug/g

241.0

243.4

0.04

252

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

124

669

1.91

10.00

3.3

2.5

ug/l

1023.8

673.4

0.37

119

646

(3023520) Reticulocytes [#/volume] in Blood

236

1531

1.61

9.98

3.2

2.6

e9/l

70.6

69.3

0.19

185

1156

(3017143) Hepatitis C virus Ab [Presence] in Serum

253

1669

1.59

9.98

2.1

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

131

721

1.87

9.95

2.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

254

1679

1.59

9.93

2.0

1.6

—

(3017181) Myelocytes/100 leukocytes in Blood

214

1361

1.64

9.80

5.0

4.3

1.0

0.02

430

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

286

1957

1.54

9.60

1.3

1.2

iu/ml

14.4

40.5

7.52

580

(3040151) Glucose [Moles/volume] in Capillary blood

206

2.62

9.51

7.1

6.2

mmol/l

7.9

7.6

0.19

175

(3012501) Base excess in Blood by calculation

395

2.12

9.09

5.7

5.4

mmol/l

2.1

2.5

0.72

266

(3044290) Cell count panel - Cerebral spinal fluid

272

2.36

9.08

1.3

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

398

2.11

8.92

1.1

—

0.8

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

394

2918

1.44

8.87

4.9

3.8

mmol/l

0.8

0.02

367

2762

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

222

1460

1.59

8.85

1.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

104

552

1.93

8.83

3.0

3.5

pmol/l

4.5

0.03

487

(3002179) Metamyelocytes/100 leukocytes in Blood

193

1233

1.63

8.67

4.8

4.1

0.7

0.6

0.16

307

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

245

1657

1.55

8.64

4.1

4.7

ug/l

33.2

26.5

0.14

202

1419

(40760892) CBC W Ordered Manual Differential panel - Blood

432

3273

1.41

8.53

5.3

4.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

113

625

1.86

8.48

1.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

198

1287

1.60

8.29

5.0

4.3

0.1

0.2

0.03

404

(3025941) Bacteria identified in Stool by Culture

122

701

1.79

8.10

1.5

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

490

1.94

8.10

1.1

1.0

—

(3004451) EKG impression Narrative

3.16

7.96

1.4

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

430

2.00

7.95

2.1

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

143

2.76

7.88

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

412

2.01

7.80

2.2

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

3.80

7.80

1.3

1.2

u/l

12.1

13.5

0.12

(3033658) Prothrombin time (PT) actual/Normal

534

4251

1.35

7.67

5.8

4.7

84.8

83.1

0.82

524

4177

(40768446) Kidney Pathology biopsy report

3.45

7.67

1.9

1.7

—

(3025159) Blasts/100 leukocytes in Blood

184

1198

1.59

7.65

5.0

4.3

0.1

0.10

329

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

438

1.96

7.56

1.4

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

237

2.31

7.55

7.7

4.5

—

(3002032) Base excess in Venous blood by calculation

247

1725

1.49

7.47

6.4

4.3

mmol/l

1.8

0.09

189

1360

(3020630) Protein [Mass/volume] in Serum or Plasma

213

1444

1.53

7.42

2.1

2.7

g/l

66.4

66.5

0.11

197

1314

(3042733) HLA Ab [Presence] in Serum

3.28

7.39

5.4

4.6

—

(3010421) pH of Blood

457

1.92

7.33

5.8

5.4

7.4

0.83

389

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.03

7.18

5.8

5.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

232

1613

1.50

7.17

2.3

2.4

g/l

0.2

0.51

214

1481

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

131

797

1.69

7.14

2.2

2.0

ug/l

5.7

2.6

0.47

121

708

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

305

2.10

6.96

4.2

3.8

58.1

0.01

305

(40758558) Short blood count panel - Blood

480

3816

1.34

6.85

8.9

7.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

118

708

1.71

6.78

3.4

3.0

u/ml

0.3

0.48

376

(3008116) Ketones [Moles/volume] in Urine by Test strip

4.28

6.75

1.5

1.1

—

(3011985) Renin [Units/volume] in Plasma

180

2.42

6.71

1.6

1.4

mu/l

85.8

78.5

0.07

163

(3021447) Carbon dioxide [Partial pressure] in Venous blood

242

1722

1.46

6.65

6.5

4.3

kpa

5.8

0.14

231

1671

(3045414) Leukocytes [Presence] in Urine

555

1.79

6.58

2.0

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

542

1.79

6.51

2.7

2.5

87.2

86.5

0.09

521

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

292

2162

1.41

6.46

4.1

4.8

u/l

234.6

239.9

0.38

280

2042

(3044927) Protein electrophoresis panel - Urine

147

2.55

6.45

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.14

6.43

3.2

2.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

107

2.83

6.43

1.8

2.1

nmol/l

16.8

17.2

0.09

100

(3051651) Icteric interference index of Serum or Plasma

107

2.83

6.43

3.3

4.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

336

2.00

6.40

1.2

1.3

u/l

25.7

49.0

0.91

298

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

112

674

1.70

6.38

3.5

2.7

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

296

2.06

6.34

3.2

3.5

e9/l

4.1

4.4

0.52

296

(3000330) Specific gravity of Urine by Test strip

112

676

1.70

6.31

4.3

3.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

251

1817

1.44

6.29

1.2

u/ml

8.1

15.2

0.75

709

(3004588) Protein electrophoresis panel - Serum or Plasma

172

1154

1.54

6.29

1.8

2.5

—

(3052851) Hemolysis interference index of Serum or Plasma

474

1.83

6.29

3.7

3.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

304

2.04

6.28

2.0

1.5

u/ml

109.8

113.5

0.08

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

402

1.90

6.27

3.6

1.5

nmol/l

0.8

0.9

0.81

348

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

284

2.07

6.26

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

168

2.41

6.22

1.3

1.4

nmol/l

0.1

0.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

306

2.02

6.17

1.4

e6/l

5.9

24.5

1.06

243

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

306

2.02

6.17

1.4

1.5

e6/l

1267.5

1065.9

0.09

258

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

293

2.04

6.14

4.4

3.0

u/ml

692.0

1848.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1587

14865

1.33

6.09

21.0

14.3

ml/min/173m2

78.6

80.4

2.43

1378

12362

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

144

936

1.58

6.06

1.6

1.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

139

896

1.59

6.06

6.0

4.6

mmol/l

24.0

0.01

123

806

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

172

2.35

5.92

1.6

1.3

pmol/l

270.6

237.3

0.26

129

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

118

2.65

5.90

1.3

1.1

—

(3019225) pH of Specimen

200

1405

1.47

5.87

6.1

4.6

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

244

2.12

5.86

2.6

—

2.8

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

112

694

1.65

5.74

4.2

3.9

mmol/l

24.6

24.7

0.14

105

643

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

315

1.97

5.72

1.8

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

401

3192

1.32

5.56

3.7

2.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

217

2.15

5.50

2.0

3.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

228

1664

1.42

5.46

1.3

—

(3006462) Nitrate [Presence] in Urine

3.48

5.45

4.2

2.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

287

1.98

5.38

1.1

iu/ml

227.8

76.1

0.49

(21494755) Public health laboratory ask at order entry panel

1518

0.61

5.38

1.3

1.4

—

(3022313) Gas panel - Capillary blood

127

828

1.57

5.31

3.9

3.7

—

(4211845)

3.30

5.31

4.1

2.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

319

1.91

5.20

2.4

2.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

145

2.37

5.16

1.4

nmol/l

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

257

2.01

5.15

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

210

2.12

5.13

2.0

1.7

—

(40761535) Cells panel - Urine sediment

167

1167

1.47

5.06

4.1

3.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

153

2.31

5.04

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

2.92

5.03

1.1

nmol/l

140.6

146.2

0.28

(3020961) Endomysium IgA Ab [Titer] in Serum

517

1.69

4.98

1.2

1.1

titre

54.0

231.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

188

1348

1.44

4.98

3.9

2.8

ml/min/173m2

52.9

65.8

3.55

502

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

187

2.16

4.92

2.0

3.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

4.08

4.90

1.0

1.4

nmol/l

103.8

152.1

0.59

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

298

1.90

4.86

1.1

u/ml

5.5

8.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

223

1656

1.39

4.84

10.2

8.8

mmol/l

1.5

1.4

0.32

215

1599

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

131

2.39

4.82

1.3

1.4

—

(3016750) Collection duration of Urine

131

2.39

4.82

2.4

2.1

min

515.0

481.9

0.67

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

343

1.83

4.78

2.0

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

309

1.87

4.69

1.4

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

360

1.80

4.68

1.5

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.04

4.67

1.7

1.5

umol/l

75.5

126.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

130

878

1.51

4.66

6.1

3.8

mmol/l

24.9

0.02

121

854

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

497

1.68

4.63

1.2

iu/ml

30.9

114.6

3.83

160

(3016018) Differential panel - Cerebral spinal fluid

147

2.27

4.58

1.5

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

134

915

1.50

4.57

1.6

g/l

1.4

1.5

0.68

116

783

(3036489) Thrombin time

101

648

1.59

4.56

2.7

2.3

23.6

21.8

0.69

580

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

235

1780

1.36

4.52

5.2

4.5

29.9

30.8

0.74

175

1222

(3001556) Androgen free Index in Serum or Plasma

10.03

4.52

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

148

2.25

4.51

1.1

—

(3023419) Bacteria identified in Sputum by Culture

229

1.99

4.46

2.2

2.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

157

1113

1.45

4.44

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.02

4.43

1.8

1.9

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

258

1.92

4.42

1.8

1.6

—

(44790047)

197

2.05

4.34

1.9

1.6

—

(44790049)

197

2.05

4.34

1.9

1.6

—

(44790048)

197

2.05

4.34

1.9

1.6

—

(44806118)

197

2.05

4.34

1.9

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

415

1.71

4.31

1.5

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.56

4.30

2.1

2.4

ng/l

147.4

163.9

—

(3051611) Lipemic interference index of Serum or Plasma

158

2.17

4.28

3.6

3.9

—

(1761482) Bacteria [#/volume] in Urine by Culture

365

1.75

4.21

5.0

3.5

—

(3024932) HLA-DR beta [Type]

2.76

4.18

1.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

256

1.90

4.18

1.7

1.6

—

(3023183) Ammonium ion [Moles/volume] in Plasma

483

1.64

4.09

3.6

3.3

umol/l

34.2

37.5

0.45

417

(3003694) ABO and Rh group [Type] in Blood

500

4239

1.24

4.05

1.4

1.3

—

(3024471) HLA-A [Type]

2.68

3.99

1.1

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

225

1.93

3.98

1.1

—

(3023410) Appearance of Cerebral spinal fluid

124

2.28

3.97

1.4

1.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

170

2.08

3.97

2.3

3.5

—

(4010399)

151

1091

1.42

3.87

1.5

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

165

2.08

3.87

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

302

2426

1.29

3.85

10.4

8.4

mmol/l

104.6

104.5

0.03

289

2370

(3004775) Volume in Urine collected for unspecified duration

186

2.01

3.84

2.6

2.2

842.7

637.7

1.91

116

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

126

2.24

3.84

1.6

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

290

2320

1.29

3.82

2.0

1.9

1.5

1.6

0.90

247

2025

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

101

2.39

3.82

1.0

1.2

mmol/l

12.6

13.0

0.09

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

196

1483

1.36

3.82

3.4

2.6

u/l

34.1

74.3

0.70

170

1307

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

320

2593

1.28

3.81

3.0

3.5

mmol/l

2.4

0.54

269

2282

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

3.20

3.77

1.8

1.2

33.3

34.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

295

1.78

3.76

1.7

1.2

u/ml

230.2

263.4

0.46

184

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

108

2.33

3.76

1.6

1.7

—

(4306422)

230

1.89

3.75

1.4

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

319

1.74

3.70

1.7

1.2

—

(4062490)

148

2.11

3.69

1.4

1.3

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

143

1033

1.41

3.69

13.0

11.9

mmol/l

23.8

24.1

0.62

136

973

(3005719) IgG [Mass/volume] in Serum or Plasma

165

1222

1.38

3.68

3.0

2.5

g/l

10.2

11.0

1.38

151

1110

(3014051) Protein [Presence] in Urine by Test strip

261

1.82

3.65

2.3

2.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

149

2.10

3.63

1.4

1.3

g/l

0.4

1.16

(3027135) IgG subclass 1 [Mass/volume] in Serum

149

2.10

3.63

1.4

1.3

g/l

6.3

6.9

0.56

(3028192) IgG subclass 2 [Mass/volume] in Serum

149

2.10

3.63

1.4

1.3

g/l

2.8

3.3

0.72

(40768800) Prostate Pathology biopsy report

571

1.55

3.62

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

500

1.58

3.60

3.4

2.7

213.8

205.1

0.31

476

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.86

3.52

1.8

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

200

1.92

3.49

1.1

2.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.35

3.48

7.6

10.0

mmol/l

5.6

6.1

0.32

(3024354) Oxygen [Partial pressure] in Venous blood

183

1391

1.35

3.47

5.0

3.4

kpa

4.8

4.6

0.33

172

1346

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

146

2.07

3.42

1.8

1.6

—

(3024928) Oxygen saturation in Venous blood

428

1.61

3.40

4.3

3.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.84

3.36

1.9

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

161

2.00

3.35

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

302

2469

1.26

3.34

29.3

27.1

inr

1.5

1.4

0.14

364

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

3.26

3.34

1.6

ug/l

8.8

9.1

0.17

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

134

975

1.40

3.34

1.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

108

2.24

3.32

1.6

1.7

—

(3017732) Neutrophils [#/volume] in Blood

130

945

1.40

3.26

2.6

3.5

e9/l

4.2

4.4

0.41

107

721

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

100

694

1.46

3.23

1.9

1.8

u/l

38.8

38.1

0.12

590

(3000475) Leukocytes [#/volume] in Synovial fluid

404

1.60

3.18

1.4

1.6

e6/l

17329.3

11670.0

0.37

289

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

2.42

3.14

1.1

1.3

ratio

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

130

955

1.39

3.08

1.8

1.9

g/l

1.2

1.4

0.55

121

872

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

202

1.85

3.08

2.0

1.8

iu/l

3.7

4.6

0.44

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

5.02

3.05

2.0

1.8

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

5.02

3.05

1.9

1.8

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

5.02

3.05

2.0

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

167

1.93

3.05

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

203

1.84

3.04

1.4

1.2

nmol/l

1.4

1.5

0.30

181

(4035726)

172

1324

1.33

3.03

1.6

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

5.85

3.02

1.0

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

347

1.63

3.01

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

347

1.63

3.01

1.4

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

100

2.21

2.99

2.1

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

475

1.54

2.98

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

242

1.75

2.95

1.4

1.3

u/ml

1.6

3.6

1.30

(3042631) Mycobacterium sp identified in Specimen

280

1.69

2.94

2.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.33

2.91

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

108

2.14

2.90

1.7

—

(3037756) Immunofixation for Serum or Plasma

359

1.61

2.89

1.4

1.9

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

2.70

2.89

3.6

5.8

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.68

2.87

5.0

6.3

umol/l

439.2

448.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

3.07

2.81

1.5

3.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.55

2.78

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.55

2.78

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

316

1.63

2.77

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

161

1.88

2.67

2.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

489

1.49

2.64

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

664

1.42

2.64

2.2

2.0

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

606

1.44

2.62

1.9

2.3

g/l

3.0

0.15

483

(3026389) Candida sp identified in Specimen by Organism specific culture

120

2.01

2.61

1.2

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.26

2.61

2.7

2.9

—

(3011412) CD3 cells [#/volume] in Blood

156

1.87

2.57

3.2

2.7

e9/l

0.8

1.0

0.83

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.36

2.55

2.7

3.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.36

2.55

2.7

3.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.36

2.55

2.7

3.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

618

1.43

2.55

1.8

2.3

g/l

10.1

10.6

0.65

525

(3000991) Gas panel - Venous blood

200

1610

1.27

2.55

14.0

10.3

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

568

1.44

2.54

2.9

2.3

ug/min

247.1

118.2

1.07

345

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

231

1.70

2.53

1.4

1.3

u/ml

3.0

4.7

0.71

112

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

579

1.43

2.49

2.0

3.8

mg/l

43.1

82.0

0.91

465

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

310

1.60

2.48

1.3

1.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

374

1.54

2.47

1.2

1.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

580

1.43

2.47

2.0

3.8

mg/l

69.8

57.9

0.51

465

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.45

2.4

2.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.45

2.4

2.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.45

2.5

2.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.15

2.45

2.4

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

159

1.84

2.44

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

336

1.56

2.42

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

2.95

2.41

1.9

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

566

1.43

2.41

2.0

3.8

ratio

2.0

4.1

—

(1761868) Lipid panel - Serum or Plasma

635

5733

1.16

2.40

3.8

3.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

467

1.47

2.39

2.2

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

290

1.60

2.37

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

2.26

2.34

3.8

4.8

u/ml

90.2

21.8

—

(3020650) Glucose [Presence] in Urine

2.87

2.30

1.4

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

212

1741

1.24

2.29

2.6

2.3

ug/l

10.9

9.8

0.12

193

1585

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

657

1.39

2.29

1.9

2.3

g/l

3.7

4.0

1.43

472

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.63

2.27

3.5

3.9

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

658

1.39

2.27

1.9

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

302

1.57

2.26

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

120

1.93

2.25

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

659

1.38

2.25

1.9

2.3

g/l

7.3

0.03

490

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

425

1.47

2.22

1.3

1.7

mg/l

2.3

4.6

1.71

299

(3024980) IgG subclass 4 [Mass/volume] in Serum

256

1.61

2.22

1.4

1.7

g/l

0.8

1.0

0.75

193

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

5.57

2.21

1.0

1.6

1.3

1.4

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

5.57

2.21

3.0

1.7

u/field

0.8

0.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

100

2.01

2.21

1.2

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.51

2.18

1.4

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

1.99

2.15

1.3

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.30

2.15

1.0

1.1

—

(4094501)

497

1.42

2.10

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

348

1.51

2.10

1.2

—

40.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

325

1.52

2.07

1.1

1.4

—

(3025577) Chromium [Mass/volume] in Blood

117

1.89

2.06

2.0

1.9

ug/l

2.7

1.7

0.48

101

(3002619) Bacteria identified in Specimen by Culture

3.51

2.05

1.4

1.2

—

(3000492) Spirometry study

193

1590

1.24

2.05

1.6

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

169

1.73

2.04

1.5

1.7

—

(3027944) Amphetamines [Presence] in Urine

475

1.42

2.04

1.7

2.8

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

215

1.64

2.04

3.2

2.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

162

1.74

2.02

1.4

promille

1.3

1.4

0.10

125

(3004809) Band form neutrophils/100 leukocytes in Blood

295

1.54

2.01

4.4

4.1

0.7

1.5

1.71

216

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

111

1.90

2.01

2.1

2.2

13.4

16.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

170

1.72

2.00

1.5

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

170

1.72

2.00

1.5

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

232

1.61

1.99

1.3

1.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

126

1.84

1.98

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.15

1.98

1.7

—

(3045424) Erythrocytes [Presence] in Urine

225

1.61

1.97

1.7

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

171

1.71

1.97

2.7

2.1

mg/l

17.5

18.9

0.12

(3007566) Smooth muscle Ab [Titer] in Serum

463

1.42

1.94

1.2

1.3

titre

46.0

94.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

363

1.47

1.94

1.7

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

4.55

1.94

6.4

3.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

610

1.36

1.90

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

196

1.64

1.90

2.2

4.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

196

1.64

1.90

2.0

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

482

1.40

1.90

1.7

2.7

—

(4146454)

189

1.65

1.88

2.7

—

(40768443) Skin Pathology biopsy report

612

1.35

1.87

1.3

1.2

—

(3008295) Osmolality of Serum or Plasma

151

1.73

1.87

1.3

mosm/kgh2o

289.7

283.9

0.46

123

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

182

1.66

1.85

2.3

2.1

—

(3003338) MCHC [Mass/volume]

1394

13406

1.13

1.80

29.9

19.3

g/l

334.7

334.8

0.08

1380

13301

(3028300) Cannabinoids [Presence] in Urine

489

1.38

1.77

1.7

2.7

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.10

1.76

1.9

2.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

447

1.40

1.76

1.9

1.6

iu/ml

0.3

15.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.34

1.74

1.0

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

117

1.80

1.74

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

117

1.80

1.74

1.0

—

(40757373) Influenza virus identified in Isolate

2.67

1.72

2.0

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

2.92

1.72

2.3

1.2

mmol/l

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.85

1.71

2.0

—

(3036603) Volume of Urine

111

1.81

1.68

1.8

1.9

1693.3

1824.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.16

1.66

1.2

1.0

—

(3027008) Opiates [Presence] in Urine

487

1.37

1.65

1.6

2.3

—

(3044941) Cell count panel - Synovial fluid

269

1.50

1.64

1.5

1.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

377

1.42

1.64

1.8

2.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.25

1.63

2.7

2.1

—

(3016879) Cocaine [Presence] in Urine

455

1.37

1.61

1.7

2.8

—

(3011288) Drugs identified in Urine by Screen method

304

1.46

1.59

1.9

3.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

280

1.47

1.57

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

207

1.55

1.57

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

305

1.45

1.57

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

114

1.76

1.56

1.9

1.8

u/field

1.7

1.4

0.20

(3025468) Yersinia sp identified in Specimen by Organism specific culture

168

1.62

1.55

1.5

1.7

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

641

1.31

1.55

3.1

4.3

u/ml

710.9

7924.6

0.98

555

(3037556) Urate [Mass/volume] in Serum or Plasma

2.04

1.54

1.2

1.4

—

(3024869) Neuronal Ab [Presence] in Serum

2.43

1.53

1.1

—

(4268621)

161

1.62

1.52

2.5

2.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.60

1.51

1.0

—

(3034988) Calcium [Moles/volume] in Capillary blood

2.60

1.51

2.3

1.4

mmol/l

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.86

1.50

1.0

—

(4133840)

2.16

1.50

1.4

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

787

1.27

1.49

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

170

1.60

1.49

1.5

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

170

1.60

1.49

1.5

1.7

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.01

1.48

1.1

1.2

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

251

1.48

4.4

5.0

umol/l

395.0

348.2

0.80

213

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.51

1.45

1.1

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

148

1.63

1.44

1.3

1.4

u/l

13.5

12.9

0.18

142

(3009015) Lactate [Moles/volume] in Synovial fluid

3.13

1.44

1.2

—

6.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.73

1.43

1.7

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

172

1.58

1.43

2.6

2.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.18

1.40

1.0

1.4

—

(3008037) Lactate [Moles/volume] in Venous blood

381

1.37

1.39

4.6

3.4

mmol/l

1.7

1.8

0.31

372

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.42

1.39

2.4

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.08

1.38

1.2

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

356

1.39

1.38

4.8

3.6

mmol/l

8.3

7.7

0.57

350

(3014765) Yersinia sp identified in Stool by Organism specific culture

365

1.38

1.37

1.6

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

365

1.38

1.37

1.6

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

365

1.38

1.37

1.6

1.2

—

(3008898) HLA-B27 [Presence]

348

1.39

1.37

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

460

1.34

1.37

2.0

2.3

g/l

0.0

0.50

414

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

306

1.41

1.36

1.5

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

1.84

1.35

1.1

1.4

u/ml

0.1

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

453

1.33

1.34

2.0

2.3

g/l

0.0

0.00

414

(3035933) Granulocytes/100 leukocytes in Blood

0.00

1.33

0.0

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

160

1.57

1.31

2.5

2.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

160

1.57

1.31

2.4

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

160

1.57

1.31

2.4

2.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.81

1.31

1.0

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

100

811

1.25

1.30

6.6

4.2

53.6

48.8

1.06

100

801

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.50

1.30

2.3

2.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.10

1.30

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

2.10

1.30

1.0

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.89

1.28

1.5

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.09

1.27

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

493

1.31

1.26

2.0

2.3

g/l

0.0

0.01

447

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.40

1.24

1.0

1.2

nmol/l

6.2

935009.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

512

1.30

1.24

1.9

2.2

g/l

36.8

37.3

0.22

437

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.77

1.23

1.1

1.2

—

(40768795) Lymph node Pathology biopsy report

142

0.49

1.20

1.6

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

559

1.28

1.20

2.4

2.5

g/l

1.2

1.3

0.16

472

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

427

1.32

1.20

1.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

307

1.38

1.18

1.5

1.6

g/l

34.5

31.6

0.70

277

(3004616) Nuclear Ab [Presence] in Serum

133

1.59

1.17

1.2

—

(3012441) Differential panel - Pleural fluid

248

1.42

1.17

1.3

1.6

—

(4027681)

1.78

1.17

1.4

1.2

—

(3025315) Body weight

2.50

1.15

5.6

3.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

126

1.59

1.14

1.1

—

(1002224) Polysomnography panel

708

1.24

1.13

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

175

1.49

1.13

3.9

3.0

mg/l

21.1

71.1

0.95

140

(3008757) Leukocyte morphology finding [Identifier] in Blood

184

1.47

1.11

4.1

4.7

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

201

1.45

1.10

1.6

1.5

65.8

61.0

0.26

130

(3017704) Immunofixation for Urine

104

1.64

1.09

1.3

1.5

—

(4198724)

1.76

1.06

2.4

4.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

211

1.43

1.06

1.3

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

211

1.43

1.06

1.3

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

120

1406

0.84

1.03

1.7

1.9

—

(4015189)

1.96

1.03

3.3

1.6

—

(4212803)

2.28

1.03

1.4

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.06

1.03

1.0

1.2

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

2.06

1.03

1.0

1.4

105.4

107.9

—

(3045716) Anion gap in Serum or Plasma

1.69

1.01

1.7

1.8

mmol/l

9.0

9.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

1.77

1.00

1.2

1.1

u/l

1.2

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

248

1.38

1.00

1.6

1.5

e6/l

34037.5

50187.4

0.39

151

(40760888) Immunoglobulin light chains.free panel - Serum

432

1.28

0.99

2.0

4.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.18

0.98

1.2

2.1

umol/l

13.8

16.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

148

1.49

0.98

1.1

1.2

u/l

53.8

63.7

0.44

102

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

124

1.54

0.96

1.0

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.86

0.96

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

250

1.37

0.96

1.4

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.77

0.94

1.6

1.3

—

46.0

—

(3048879) Bone marrow aspiration report

1.78

0.94

1.1

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

1.72

0.92

2.2

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.73

0.92

9.0

7.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

518

1.24

0.91

1.7

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.75

0.90

8.9

7.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.69

0.88

8.3

7.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.69

0.88

1.2

1.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

119

1.52

0.88

1.4

1.6

umol/l

14.5

14.1

0.10

112

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.79

0.87

1.2

1.1

—

(3014007) Fractional oxyhemoglobin in Arterial blood

145

1272

1.15

0.87

14.0

11.1

92.4

93.8

0.97

145

1266

(3000093) Morphology [Interpretation] in Blood Narrative

186

1.40

0.87

1.3

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

2.00

0.87

1.0

1.4

—

(3022689) Creatine [Moles/volume] in Urine

1.82

0.86

2.4

1.4

—

(3045142) Bone marrow Pathology biopsy report

221

1.36

0.85

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.57

0.84

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

698

1.20

0.84

1.5

1.6

—

(3023199) Leukocytes [#/volume] in Pleural fluid

266

1.32

0.82

1.6

e6/l

2001.0

1629.6

0.28

188

(3019977) pH of Arterial blood

113

1.51

0.82

1.6

2.8

7.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

163

1.42

0.82

1.5

1.3

e6/l

291065.6

57019.2

—

117

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.55

0.81

3.3

3.5

—

(40768441) Liver Pathology biopsy report

114

1.50

0.79

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.51

0.78

1.8

2.3

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

157

1.41

0.76

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

1.64

0.73

1.0

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.61

0.72

1.0

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

1.53

0.72

2.3

2.9

—

(3045788) Cell count panel - Pleural fluid

203

1.33

0.70

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.93

0.70

1.2

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

170

0.65

0.70

1.1

u/ml

7.7

7.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

265

1.29

0.70

1.1

u/ml

1.6

3.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

266

1.28

0.68

1.1

u/ml

3.5

4.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.67

0.68

1.9

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

520

1.20

0.68

1.7

1.2

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

143

1280

1.13

0.68

13.9

10.9

1.3

1.4

0.64

143

1267

(3020491) Glucose [Moles/volume] in Blood

102

1.47

0.67

1.3

2.2

mmol/l

9.5

7.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

357

1.24

0.66

1.8

1.5

—

(3011648) Oxygen content in Venous blood

171

1.35

0.65

4.0

2.1

9.2

11.2

1.44

171

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.59

0.65

1.7

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.59

0.65

1.4

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.59

0.65

1.6

1.1

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

142

1275

1.12

0.65

14.0

11.0

0.6

0.7

1.02

142

1258

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.73

0.64

1.4

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

129

1.40

0.63

3.6

2.6

e6/l

609.2

525.6

—

(3000012) Reticulocyte production index

1.52

0.62

2.4

1.4

—

(3021788) Differential panel - Synovial fluid

297

1.25

0.62

1.3

1.5

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.64

0.62

1.1

1.4

—

(3034426) Prothrombin time (PT)

1.59

0.61

1.5

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.60

0.61

1.1

1.2

miu/ml

1499.6

1459.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

290

1.25

0.59

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.54

0.59

1.3

1.6

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

255

1.26

0.58

1.5

1.6

—

(21494434) Karyotype in Bone marrow

184

1.31

0.58

1.0

1.2

—

(44806420)

1.46

0.56

2.1

2.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1.45

0.55

1.5

1.6

u/l

13.7

5.9

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.47

0.54

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

241

1.25

0.52

1.3

1.2

miu/ml

268.0

161.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.43

0.52

5.1

3.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

1.41

0.51

1.2

ug/l

6.8

8.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.41

0.51

2.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

306

1.21

0.50

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.50

0.49

9.4

1.5

169.6

191.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.56

0.49

1.7

6.9

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

200

1.25

0.46

4.7

4.5

63.0

60.2

0.25

114

(3047189) Immunofixation for 24 hour Urine

103

1.36

0.45

1.1

2.1

—

(4024509)

1.40

0.44

1.6

1.3

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.61

0.43

2.0

1.9

pmol/l

92.5

26.4

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.61

0.43

1.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

443

1.16

0.42

1.6

1.7

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.38

0.42

6.5

3.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.52

0.41

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

105

1.34

0.41

1.3

1.4

—

73.0

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.39

0.40

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.39

0.40

1.2

1.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.40

0.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.40

0.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

193

0.78

0.39

1.0

1.1

u/ml

0.2

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.4

—

47.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

160

1.25

0.38

3.1

1.8

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.33

0.37

1.2

1.4

—

56.0

—

(4281824)

0.65

0.35

1.6

1.4

—

(3017569) Oxygen content in Arterial blood

1.32

0.35

2.2

2.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

211

0.80

0.34

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.34

1.0

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

100

1.30

0.33

1.2

1.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

303

1.16

0.33

3.5

2.6

nmol/l

0.8

0.01

226

(3023420) DNA double strand Ab [Units/volume] in Serum

120

1.25

0.30

1.0

1.2

—

20.8

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.23

0.29

1.0

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

158

1.20

0.28

1.2

1.1

titre

74.0

95.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

158

1.20

0.28

1.2

1.1

—

125.0

—

(3003181) Sodium [Moles/volume] in Urine

252

1.15

0.27

1.2

1.3

mmol/l

63.1

65.7

0.13

207

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.67

0.26

3.6

2.3

nmol/l

86.2

134.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

208

1992

1.05

0.25

9.7

7.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

151

1.19

0.25

1.1

1.3

—

(3020891) Body temperature

784

1.07

0.24

5.3

4.8

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

190

1.16

0.23

3.3

3.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

125

0.80

0.23

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.25

0.22

1.2

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.19

0.21

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.19

0.21

1.0

2.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.19

0.21

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.19

0.21

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.19

0.21

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

4.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.21

0.0

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.21

0.0

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.23

0.21

1.2

2.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.21

0.0

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

127

1.18

0.19

2.3

1.5

g/l

0.8

1.0

0.60

127

(3032773) Endomysium IgG Ab [Titer] in Serum

1.22

0.19

1.1

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

1.24

0.18

11.5

13.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.17

0.17

1.1

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.13

0.17

2.0

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.13

0.17

2.0

2.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.13

0.16

1.0

1.1

iu/ml

342.0

246.0

—

(3033799) Differential panel - Peritoneal fluid

1.11

0.16

3.7

2.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.11

0.15

1.1

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.11

0.15

1.1

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

169

1.13

0.14

1.1

—

2.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

198

1.11

0.14

1.1

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

160

0.87

0.14

1.4

1.5

17.6

24.7

—

103

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

171

1.11

0.12

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

104

1.15

0.12

4.0

2.6

40.2

34.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

158

0.89

0.12

1.0

1.1

u/ml

0.2

2.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

354

0.93

0.12

2.7

3.2

mg/l

28.3

29.6

0.05

222

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.14

0.10

1.0

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.14

0.10

2.2

4.3

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.09

0.09

1.2

1.0

—

5.4

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.15

0.09

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

438

1.05

0.09

1.3

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.07

0.08

2.5

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.07

0.08

5.3

6.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.05

0.08

1.3

1.2

—

0.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.79

0.08

1.0

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.78

0.08

1.0

1.1

—

(44813793)

1.06

0.08

1.0

—

(3035880) pH of Pleural fluid

127

1.10

0.08

1.5

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

0.82

0.07

2.0

2.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.86

0.07

1.3

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.86

0.07

1.3

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.86

0.07

1.3

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.84

0.07

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.84

0.07

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.84

0.07

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

0.83

0.07

2.0

2.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.83

0.07

1.1

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

880

0.98

0.06

1.3

1.5

—

(4034850)

522

0.98

0.03

13.6

10.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

159

0.94

0.03

1.2

1.0

u/ml

4.3

2.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

103

1019

1.01

0.02

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

157

0.96

0.01

1.3

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

126

0.95

0.00

1.0

1.1

u/ml

4.0

1.9

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

126

0.95

0.00

1.4

1.5

—

75.2

—

(3024263) Appearance of Synovial fluid

1.05

0.00

1.6

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

138

1.01

0.00

1.0

1.1

u/ml

2.0

2.5

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.01

0.00

1.0

1.1

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

1.9

—

(3044336) Cobalt [Moles/volume] in Urine

0.00

0.0

2.1

—

19.5

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

21.4

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

10.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(3051671) S100 calcium binding protein B [Mass/volume] in Serum

0.00

0.0

2.2

—

0.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.8

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.0

—

39.2

—

(3015183) Erythrocyte sedimentation rate

0.94

0.00

1.3

1.2

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

3.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

1.00

0.00

2.1

2.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

7.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.95

0.00

1.1

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.00

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

0.97

0.00

1.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.0

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_IMPOTENCE and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
N14_IMPOTENCE	1.27 [1.16, 1.39]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.084

During the follow-up period (1.1.1998 — 31.12.2019), 1515 out of 7025 males with N14_IMPOTENCE died.

Mortality risk

Mortality risk for people of age

years, who have N14_IMPOTENCE.

N-year risk	Females	Males
1	No data	0.285%
5	No data	1.865%
10	No data	4.533%
15	No data	8.42%
20	No data	13.963%

Relationships between endpoints

↥

Index endpoint: N14_IMPOTENCE – Impotence

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Impotence

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints